Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation
PONTE VEDRA, Fla., July 21, 2026 (GLOBE NEWSWIRE) -- NASDAQ:CVKD">Cadrenal Therapeutics, Inc. NASDAQ:CVKD, a late-stage biopharmaceutical company advancing specialized therapies for critical care cardiology and orphan cardiovascular conditions, today announced a comprehensive alignment of its clini…